News

Nucleic acid immunity involves a sophisticated set of mechanisms for identifying nucleic acids by immune receptors, playing a vital role in physiological ...
Mursla’s AI Precision Medicine is built on the ability to isolate and analyze EVs which are secreted by specific organs into ...
The tumor suppressor p53 is a transcription factor that controls the expression of hundreds of genes. Emerging evidence suggests that the p53-induced RNA-binding protein ZMAT3 is a key splicing ...
Spatial metabolomics is transforming our understanding of microbial systems by uncovering the localized molecular dynamics ...
Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to advance precision diagnostics and significantly improve cancer outcomes for at-risk patients, today announced the commercial ...
For more information about the new nucleic acid extraction claim for BioCode® GPP or to learn more about Applied BioCode’s innovative diagnostic solutions, please visit https://www.apbiocode ...
The reversible and noncovalent nature of the interactions governing the structure and binding properties of nucleic acids mean that the fields of supramolecular chemistry and nucleic acid chemistry ...
Suppression of Ehrlich ascites tumor cell proliferation via G1 arrest induced by dietary nucleic acid-derived nucleosides. PLOS ONE, 2024; 19 (7): e0305775 DOI: 10.1371/journal.pone.0305775; ...
An innovative programmable tool for targeting nucleic acids has been created, utilizing a prokaryotic immune defense system—and it is not CRISPR-Cas. Russian Academy of Sciences researchers have ...
The first-ever private mission Venus aims to search for signs of life in its clouds by detecting organic chemistry. It is slated to launch in 2025.